Biolab study finds optimal time interval between AstraZeneca doses

AMMAN — The founder and CEO of Biolab Medical Laboratory, Dr Amid Abdel Nour, said that the Biolab Laboratory has conducted scientific research on less than 40 people in order to study the immunological efficacy of the AstraZeneca vaccine and the optimal time interval between the two doses to achieve the best results. اضافة اعلان

As stated by Dr Abdel Nour, the preliminary results of the study indicate that the time interval between the two doses of the AstraZeneca vaccine in Jordan, which was taken earlier by the health authorities in the Kingdom, was a safe decision. 

Issa Abu Dayh, head of the Scientific Research Department at Biolab, who heads the scientific team, confirmed that the preliminary results indicate that the antibodies to the coronavirus reached their maximum values in the majority of participants 8 weeks after receiving the first dose, which indicates that those vaccinated develop Immunity against the  virus between the eighth week and the tenth week. The study results are similar to  international studies and the recommendations of AstraZeneca.

Read more national news